Global Dolutegravir Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
- MAI4662116
- 118 Pages
- October 2021
- Pharmaceuticals
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Dolutegravir market covered in Chapter 5:
Mylan
Adcock Ingram Limited
ViiV Healthcare (GSK)
LAURUS Labs
Aurobindo Pharma
Shanghai Desano Pharmaceuticals
In Chapter 6, on the basis of types, the Dolutegravir market from 2015 to 2025 is primarily split into:
10mg Tablets
50mg Tablets
In Chapter 7, on the basis of applications, the Dolutegravir market from 2015 to 2025 covers:
Prevent HIV Infection Following Potential Exposure
Other
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Dolutegravir Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 Analysis of Leading Companies
5.1 Mylan
5.1.1 Mylan Company Profile
5.1.2 Mylan Business Overview
5.1.3 Mylan Dolutegravir Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Mylan Dolutegravir Products Introduction
5.2 Adcock Ingram Limited
5.2.1 Adcock Ingram Limited Company Profile
5.2.2 Adcock Ingram Limited Business Overview
5.2.3 Adcock Ingram Limited Dolutegravir Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Adcock Ingram Limited Dolutegravir Products Introduction
5.3 ViiV Healthcare (GSK)
5.3.1 ViiV Healthcare (GSK) Company Profile
5.3.2 ViiV Healthcare (GSK) Business Overview
5.3.3 ViiV Healthcare (GSK) Dolutegravir Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 ViiV Healthcare (GSK) Dolutegravir Products Introduction
5.4 LAURUS Labs
5.4.1 LAURUS Labs Company Profile
5.4.2 LAURUS Labs Business Overview
5.4.3 LAURUS Labs Dolutegravir Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 LAURUS Labs Dolutegravir Products Introduction
5.5 Aurobindo Pharma
5.5.1 Aurobindo Pharma Company Profile
5.5.2 Aurobindo Pharma Business Overview
5.5.3 Aurobindo Pharma Dolutegravir Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Aurobindo Pharma Dolutegravir Products Introduction
5.6 Shanghai Desano Pharmaceuticals
5.6.1 Shanghai Desano Pharmaceuticals Company Profile
5.6.2 Shanghai Desano Pharmaceuticals Business Overview
5.6.3 Shanghai Desano Pharmaceuticals Dolutegravir Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Shanghai Desano Pharmaceuticals Dolutegravir Products Introduction
6 Market Analysis and Forecast, By Product Types
6.1 Global Dolutegravir Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Dolutegravir Sales and Market Share by Types (2015-2020)
6.1.2 Global Dolutegravir Revenue and Market Share by Types (2015-2020)
6.1.3 Global Dolutegravir Price by Types (2015-2020)
6.2 Global Dolutegravir Market Forecast by Types (2020-2025)
6.2.1 Global Dolutegravir Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Dolutegravir Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Dolutegravir Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Dolutegravir Sales, Price and Growth Rate of 10mg Tablets
6.3.2 Global Dolutegravir Sales, Price and Growth Rate of 50mg Tablets
6.4 Global Dolutegravir Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 10mg Tablets Market Revenue and Sales Forecast (2020-2025)
6.4.2 50mg Tablets Market Revenue and Sales Forecast (2020-2025)
7 Market Analysis and Forecast, By Applications
7.1 Global Dolutegravir Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Dolutegravir Sales and Market Share by Applications (2015-2020)
7.1.2 Global Dolutegravir Revenue and Market Share by Applications (2015-2020)
7.2 Global Dolutegravir Market Forecast by Applications (2020-2025)
7.2.1 Global Dolutegravir Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Dolutegravir Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Dolutegravir Revenue, Sales and Growth Rate of Prevent HIV Infection Following Potential Exposure (2015-2020)
7.3.2 Global Dolutegravir Revenue, Sales and Growth Rate of Other (2015-2020)
7.4 Global Dolutegravir Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Prevent HIV Infection Following Potential Exposure Market Revenue and Sales Forecast (2020-2025)
7.4.2 Other Market Revenue and Sales Forecast (2020-2025)
8 Market Analysis and Forecast, By Regions
8.1 Global Dolutegravir Sales by Regions (2015-2020)
8.2 Global Dolutegravir Market Revenue by Regions (2015-2020)
8.3 Global Dolutegravir Market Forecast by Regions (2020-2025)
9 North America Dolutegravir Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Dolutegravir Market Sales and Growth Rate (2015-2020)
9.3 North America Dolutegravir Market Revenue and Growth Rate (2015-2020)
9.4 North America Dolutegravir Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Dolutegravir Market Analysis by Country
9.6.1 U.S. Dolutegravir Sales and Growth Rate
9.6.2 Canada Dolutegravir Sales and Growth Rate
9.6.3 Mexico Dolutegravir Sales and Growth Rate
10 Europe Dolutegravir Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Dolutegravir Market Sales and Growth Rate (2015-2020)
10.3 Europe Dolutegravir Market Revenue and Growth Rate (2015-2020)
10.4 Europe Dolutegravir Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Dolutegravir Market Analysis by Country
10.6.1 Germany Dolutegravir Sales and Growth Rate
10.6.2 United Kingdom Dolutegravir Sales and Growth Rate
10.6.3 France Dolutegravir Sales and Growth Rate
10.6.4 Italy Dolutegravir Sales and Growth Rate
10.6.5 Spain Dolutegravir Sales and Growth Rate
10.6.6 Russia Dolutegravir Sales and Growth Rate
11 Asia-Pacific Dolutegravir Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Dolutegravir Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Dolutegravir Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Dolutegravir Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Dolutegravir Market Analysis by Country
11.6.1 China Dolutegravir Sales and Growth Rate
11.6.2 Japan Dolutegravir Sales and Growth Rate
11.6.3 South Korea Dolutegravir Sales and Growth Rate
11.6.4 Australia Dolutegravir Sales and Growth Rate
11.6.5 India Dolutegravir Sales and Growth Rate
12 South America Dolutegravir Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Dolutegravir Market Sales and Growth Rate (2015-2020)
12.3 South America Dolutegravir Market Revenue and Growth Rate (2015-2020)
12.4 South America Dolutegravir Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Dolutegravir Market Analysis by Country
12.6.1 Brazil Dolutegravir Sales and Growth Rate
12.6.2 Argentina Dolutegravir Sales and Growth Rate
12.6.3 Columbia Dolutegravir Sales and Growth Rate
13 Middle East and Africa Dolutegravir Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Dolutegravir Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Dolutegravir Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Dolutegravir Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Dolutegravir Market Analysis by Country
13.6.1 UAE Dolutegravir Sales and Growth Rate
13.6.2 Egypt Dolutegravir Sales and Growth Rate
13.6.3 South Africa Dolutegravir Sales and Growth Rate
14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 Appendix
15.1 Methodology
15.2 Research Data Source
List of Tables and Figures
Figure Product Picture
Figure Global Dolutegravir Market Size and Growth Rate 2015-2025
Table Dolutegravir Key Market Segments
Figure Global Dolutegravir Market Revenue ($) Segment by Type from 2015-2020
Figure Global Dolutegravir Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Dolutegravir
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Mylan Company Profile
Table Mylan Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Mylan Production and Growth Rate
Figure Mylan Market Revenue ($) Market Share 2015-2020
Table Adcock Ingram Limited Company Profile
Table Adcock Ingram Limited Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Adcock Ingram Limited Production and Growth Rate
Figure Adcock Ingram Limited Market Revenue ($) Market Share 2015-2020
Table ViiV Healthcare (GSK) Company Profile
Table ViiV Healthcare (GSK) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure ViiV Healthcare (GSK) Production and Growth Rate
Figure ViiV Healthcare (GSK) Market Revenue ($) Market Share 2015-2020
Table LAURUS Labs Company Profile
Table LAURUS Labs Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure LAURUS Labs Production and Growth Rate
Figure LAURUS Labs Market Revenue ($) Market Share 2015-2020
Table Aurobindo Pharma Company Profile
Table Aurobindo Pharma Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Aurobindo Pharma Production and Growth Rate
Figure Aurobindo Pharma Market Revenue ($) Market Share 2015-2020
Table Shanghai Desano Pharmaceuticals Company Profile
Table Shanghai Desano Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Shanghai Desano Pharmaceuticals Production and Growth Rate
Figure Shanghai Desano Pharmaceuticals Market Revenue ($) Market Share 2015-2020
Table Global Dolutegravir Sales by Types (2015-2020)
Table Global Dolutegravir Sales Share by Types (2015-2020)
Table Global Dolutegravir Revenue ($) by Types (2015-2020)
Table Global Dolutegravir Revenue Share by Types (2015-2020)
Table Global Dolutegravir Price ($) by Types (2015-2020)
Table Global Dolutegravir Market Forecast Sales by Types (2020-2025)
Table Global Dolutegravir Market Forecast Sales Share by Types (2020-2025)
Table Global Dolutegravir Market Forecast Revenue ($) by Types (2020-2025)
Table Global Dolutegravir Market Forecast Revenue Share by Types (2020-2025)
Figure Global 10mg Tablets Sales and Growth Rate (2015-2020)
Figure Global 10mg Tablets Price (2015-2020)
Figure Global 50mg Tablets Sales and Growth Rate (2015-2020)
Figure Global 50mg Tablets Price (2015-2020)
Figure Global Dolutegravir Market Revenue ($) and Growth Rate Forecast of 10mg Tablets (2020-2025)
Figure Global Dolutegravir Sales and Growth Rate Forecast of 10mg Tablets (2020-2025)
Figure Global Dolutegravir Market Revenue ($) and Growth Rate Forecast of 50mg Tablets (2020-2025)
Figure Global Dolutegravir Sales and Growth Rate Forecast of 50mg Tablets (2020-2025)
Table Global Dolutegravir Sales by Applications (2015-2020)
Table Global Dolutegravir Sales Share by Applications (2015-2020)
Table Global Dolutegravir Revenue ($) by Applications (2015-2020)
Table Global Dolutegravir Revenue Share by Applications (2015-2020)
Table Global Dolutegravir Market Forecast Sales by Applications (2020-2025)
Table Global Dolutegravir Market Forecast Sales Share by Applications (2020-2025)
Table Global Dolutegravir Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Dolutegravir Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Prevent HIV Infection Following Potential Exposure Sales and Growth Rate (2015-2020)
Figure Global Prevent HIV Infection Following Potential Exposure Price (2015-2020)
Figure Global Other Sales and Growth Rate (2015-2020)
Figure Global Other Price (2015-2020)
Figure Global Dolutegravir Market Revenue ($) and Growth Rate Forecast of Prevent HIV Infection Following Potential Exposure (2020-2025)
Figure Global Dolutegravir Sales and Growth Rate Forecast of Prevent HIV Infection Following Potential Exposure (2020-2025)
Figure Global Dolutegravir Market Revenue ($) and Growth Rate Forecast of Other (2020-2025)
Figure Global Dolutegravir Sales and Growth Rate Forecast of Other (2020-2025)
Figure Global Dolutegravir Sales and Growth Rate (2015-2020)
Table Global Dolutegravir Sales by Regions (2015-2020)
Table Global Dolutegravir Sales Market Share by Regions (2015-2020)
Figure Global Dolutegravir Sales Market Share by Regions in 2019
Figure Global Dolutegravir Revenue and Growth Rate (2015-2020)
Table Global Dolutegravir Revenue by Regions (2015-2020)
Table Global Dolutegravir Revenue Market Share by Regions (2015-2020)
Figure Global Dolutegravir Revenue Market Share by Regions in 2019
Table Global Dolutegravir Market Forecast Sales by Regions (2020-2025)
Table Global Dolutegravir Market Forecast Sales Share by Regions (2020-2025)
Table Global Dolutegravir Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Dolutegravir Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Dolutegravir Market Sales and Growth Rate (2015-2020)
Figure North America Dolutegravir Market Revenue and Growth Rate (2015-2020)
Figure North America Dolutegravir Market Forecast Sales (2020-2025)
Figure North America Dolutegravir Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Dolutegravir Market Sales and Growth Rate (2015-2020)
Figure Canada Dolutegravir Market Sales and Growth Rate (2015-2020)
Figure Mexico Dolutegravir Market Sales and Growth Rate (2015-2020)
Figure Europe Dolutegravir Market Sales and Growth Rate (2015-2020)
Figure Europe Dolutegravir Market Revenue and Growth Rate (2015-2020)
Figure Europe Dolutegravir Market Forecast Sales (2020-2025)
Figure Europe Dolutegravir Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Dolutegravir Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Dolutegravir Market Sales and Growth Rate (2015-2020)
Figure France Dolutegravir Market Sales and Growth Rate (2015-2020)
Figure Italy Dolutegravir Market Sales and Growth Rate (2015-2020)
Figure Spain Dolutegravir Market Sales and Growth Rate (2015-2020)
Figure Russia Dolutegravir Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Dolutegravir Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Dolutegravir Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Dolutegravir Market Forecast Sales (2020-2025)
Figure Asia-Pacific Dolutegravir Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Dolutegravir Market Sales and Growth Rate (2015-2020)
Figure Japan Dolutegravir Market Sales and Growth Rate (2015-2020)
Figure South Korea Dolutegravir Market Sales and Growth Rate (2015-2020)
Figure Australia Dolutegravir Market Sales and Growth Rate (2015-2020)
Figure India Dolutegravir Market Sales and Growth Rate (2015-2020)
Figure South America Dolutegravir Market Sales and Growth Rate (2015-2020)
Figure South America Dolutegravir Market Revenue and Growth Rate (2015-2020)
Figure South America Dolutegravir Market Forecast Sales (2020-2025)
Figure South America Dolutegravir Market Forecast Revenue ($) (2020-2025)
Figure Brazil Dolutegravir Market Sales and Growth Rate (2015-2020)
Figure Argentina Dolutegravir Market Sales and Growth Rate (2015-2020)
Figure Columbia Dolutegravir Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Dolutegravir Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Dolutegravir Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Dolutegravir Market Forecast Sales (2020-2025)
Figure Middle East and Africa Dolutegravir Market Forecast Revenue ($) (2020-2025)
Figure UAE Dolutegravir Market Sales and Growth Rate (2015-2020)
Figure Egypt Dolutegravir Market Sales and Growth Rate (2015-2020)
Figure South Africa Dolutegravir Market Sales and Growth Rate (2015-2020)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
